-
Cancer patients are living longer than ever. Pain drugmakers haven’t kept up.
25 Sep 2025 13:01 GMT
… diverse range of pharmaceutical options for cancer … this one drug.
Cyclobenzaprine is an old medication used to … cancer centers, doctors are experimenting with layered treatment approaches, combining … induced neuropathy.
Smaller biotechs also continue to take …
-
Tonix Pharmaceuticals Announces Positive Pre-IND Meeting with FDA for TNX-102 SL for the Treatment of Major Depressive Disorder
18 Sep 2025 12:00 GMT
… . Tonix Pharmaceuticals Holding Corp. Tonix Pharmaceuticals is a fully-integrated biotechnology company with … during treatment initiation or dosage increases. Tricyclic antidepressant-like adverse reactions: Cyclobenzaprine is …
-
Tonix Pharmaceuticals Announces In-licensing Phase 2/3-Ready Monoclonal Antibody Designed for Seasonal Prevention of Lyme Disease (TNX-4800)
17 Sep 2025 11:00 GMT
… ). Tonix Pharmaceuticals Holding Corp.* Tonix Pharmaceuticals is a fully-integrated biotechnology company with … during treatment initiation or dosage increases. Tricyclic antidepressant-like adverse reactions: Cyclobenzaprine is …
-
New Clinical Data on Tonmya for the Treatment of Fibromyalgia
10 Sep 2025 09:05 GMT
… sublingual tablet formulation of cyclobenzaprine hydrochloride, which provides … and Drug Administration (FDA) approved Tonmya for the treatment of … executive officer of Tonix Pharmaceuticals. “The data presented … endpoint across both trials was the daily diary …
-
Drug prescription in Canada reminds me how lucky the UK is
10 Sep 2025 13:39 GMT
… , bulging with the innumerable new drug treatments modern medical science has devised, but … many pharmaceuticals I’d never even heard of. One example: Canadian doctors … and patients are enamoured of a drug called cyclobenzaprine, used …
-
Tonix Pharmaceuticals Presents Clinical Data on Tonmya™ for the Treatment of Fibromyalgia at PAINWEEK 2025
08 Sep 2025 11:00 GMT
… 3 Clinical Trials: RELIEF … Pharmaceuticals Holding Corp.* Tonix Pharmaceuticals is a fully-integrated biotechnology … analgesic medicine for the treatment … treatment initiation or dosage increases. Tricyclic antidepressant-like adverse reactions: Cyclobenzaprine …
-
Tonix Pharmaceuticals Announces FDA Approval of Tonmya™ (cyclobenzaprine HCl sublingual tablets) for the Treatment of Fibromyalgia
15 Aug 2025 19:44 GMT
… Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a fully-integrated biotechnology … Drug Administration (FDA) approved Tonmya™ (cyclobenzaprine HCl sublingual tablets) for the treatment … trial, RESILIENT, was recently published in Pain Medicine … antidepressants, …
-
Alzheimer’s Therapy Is Coming to the Home With FDA Approval of Injectable Eisai, Biogen Drug
02 Sep 2025 13:18 GMT
… .
—FDA approval of Ionis Pharmaceuticals drug Dawnzera gives the biotech entry … authorization covers the treatment of adults with … pharmaceutical ingredient in Tonmya is the old muscle relaxant cyclobenzaprine … as an adjunct to statin therapy. The latest …
-
Unichem Pharma USA recalls one lot of Cyclobenzaprine Hydrochloride Tablets 10 mg over mislabeling
03 Sep 2025 17:07 GMT
… Pharmaceuticals (USA), Inc. is voluntarily recalling one lot of Cyclobenzaprine … concomitant nonsteroidal anti-Inflammatory drugs and/or blood … not further distribute, this medication, and notify their customers … be reported to the FDA's MedWatch …
-
Unichem Pharmaceuticals recalls mislabeled Cyclobenzaprine tablets in US over safety concerns
03 Sep 2025 09:13 GMT
… , bottles labeled as Cyclobenzaprine 10 mg (commonly … US Food and Drug Administration (FDA). Consumers experiencing side … strict quality checks in pharmaceutical packaging and labeling, … of mislabeling in prescription medications.
Aditya Bhagchandani serves …